Press Release: RoosterBio : NanoFCM Partners with RoosterBio as an Approved Service Provider for Exosome Analysis
FREDERICK, Md. (PRWEB) April 26, 2023 NanoFCM Co., Ltd today announced that RoosterBio, Inc. a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, development services, cell engineering, and advanced therapy bioprocess...
Read full article »
RoosterBio is a Maryland-based biotechnology company that develops products such as stromal cells and human exosomes for cell and gene therapy applications.
Read more